| scholarly article | Q13442814 |
| P50 | author | Antonio Paoli | Q56938375 |
| P2093 | author name string | Devanand Mangar | |
| Enrico Camporesi | |||
| Gerardo Bosco | |||
| Prachiti Dalvi | |||
| Silvia Quartesan | |||
| Zhongjin Yang | |||
| Giuliano Vezzani | |||
| Thomas Bernasek | |||
| Pasqua Cancellara | |||
| Alex Rizzato | |||
| P2860 | cites work | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Avascular Necrosis of the Femoral Head: Are Any Genes Involved? | Q26799377 | ||
| Structural and functional insights of RANKL-RANK interaction and signaling | Q27661741 | ||
| Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 | ||
| Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro | Q34459310 | ||
| Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling | Q34636733 | ||
| Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis | Q35843398 | ||
| The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling | Q35961678 | ||
| Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway | Q36261410 | ||
| Immunology of Osteoporosis: A Mini-Review | Q36766801 | ||
| Avascular necrosis of the femoral head in HIV positive patients-an assessment of risk factors and early response to surgical treatment | Q37201807 | ||
| Management of avascular necrosis of femoral head at pre-collapse stage | Q37596992 | ||
| Mechanisms of action of hyperbaric oxygen therapy | Q38225255 | ||
| Hyperbaric oxygen therapy accelerates osteoblast differentiation and promotes bone formation. | Q38934003 | ||
| Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis | Q39118073 | ||
| NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis | Q44049672 | ||
| Hyperbaric oxygen therapy suppresses osteoclast formation and bone resorption. | Q44404368 | ||
| Femoral head osteonecrosis can be caused by disruption of the systemic immune response via the toll-like receptor 4 signalling pathway | Q46171887 | ||
| Hyperbaric oxygen for stage I and II femoral head osteonecrosis. | Q50594392 | ||
| There may be a role for hyperbaric oxygen therapy in transient osteoporosis of the hip. | Q51295523 | ||
| Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. | Q52192178 | ||
| Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment | Q67275256 | ||
| Natural history of nontraumatic avascular necrosis of the femoral head | Q68190540 | ||
| Effect of hyperbaric oxygen on murine neutrophil and T-lymphocyte functions | Q68903164 | ||
| Hyperbaric oxygen therapy as a treatment for stage-I avascular necrosis of the femoral head | Q73347446 | ||
| Lesions of the menisci of the knee: value of MR imaging criteria for recognition of unstable lesions | Q73549547 | ||
| Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent | Q74199804 | ||
| Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function | Q74244387 | ||
| [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head] | Q79776390 | ||
| Hyperbaric oxygen therapy in femoral head necrosis | Q84574788 | ||
| Hyperbaric oxygen therapy improved both pain scores and range of motion in patients with early idiopathic femoral head necrosis (Ficat stage II) | Q84779689 | ||
| Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis | Q86666626 | ||
| Effect of hyperbaric oxygen therapy on tooth extraction sites in rats subjected to bisphosphonate therapy-histomorphometric and immunohistochemical analysis | Q87422028 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | oxygen therapy | Q1988216 |
| P304 | page(s) | 707-711 | |
| P577 | publication date | 2017-12-01 | |
| P1433 | published in | Journal of Enzyme Inhibition and Medicinal Chemistry | Q15708877 |
| P1476 | title | Hyperbaric oxygen therapy modulates serum OPG/RANKL in femoral head necrosis patients | |
| P478 | volume | 32 |
| Q90600722 | Femoral condylar necrosis: treatment with hyperbaric oxygen therapy |
| Q89862403 | Hyperbaric Oxygen Therapy Improves the Osteogenic and Vasculogenic Properties of Mesenchymal Stem Cells in the Presence of Inflammation In Vitro |
| Q57023569 | Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress |
| Q83547444 | Protective effect of Agrimonia pilosa polysaccharides on dexamethasone-treated MC3T3-E1 cells via Wnt/β-Catenin pathway |
| Q57470385 | Stage III Kienböck's disease treated with hyperbaric oxygen: the role of an unusual approach to a rare condition |
Search more.